Make your voice heard. Learn about 340B legislation at the state level and federal reform efforts in Washington.

Prohibitions Against Discriminatory Practices Related to 340B Entities and Drugs

HB 1281
Read the Bill

• 1/8/26 – Introduced
• 1/13/26 – First Reading
• 1/15/26 – Referred to Health Care Facilities & Systems Subcommittee, Insurance & Banking Subcommittee, and Health & Human Services Committee

SB 1638
Read the Bill

• 1/9/26 – Introduced

Requires an audit of the 340B program in Illinois.

Read the Bill

• 1/7/26 – Introduced
• 1/14/26 – Referred to Rules Committee

Regulation of 340B Drug Manufacturers and Distributors

HF 2009
Read the Bill

• 1/13/26 – Introduced + Referred to Health and Human Services
• 1/14/26 – Assigned to Subcommittee
• 1/21/26 – Subcommittee recommends passage

Prohibiting Discrimination Against 340B Drug Entities

H.785
Read the Bill

• 3/31/25 – Referred to Financial Services
• 6/3/25 – Joint Hearing
• 9/18/25 – Reported Favorably + Referred to Health Care Financing
• 12/8/25 – Reporting date extended to 3/8/26

H.1296
Read the Bill

• 6/3/25 – Joint Hearing

H.4495
Read the Bill

• 9/18/25 – Reported from Financial Services + Referred to Health Care Financing
• 12/8/25 – Reporting date extended to 3/8/26

S.779
Read the Bill

• 6/3/25 – Joint Hearing
• 12/4/25 – Senate Study Order

Prohibitions Against Discriminatory Practices Related to 340B Entities and Drugs

HB 4878
Read the Bill

• 9/11/25 – Introduced and referred to Committee on Health Policy

SB 94
Read the Bill

• 2/20/25 – Introduced and referred to Committee on Oversight
• 2/26/25 – Reported Favorably Without Amendment & Referred to Committee of the Whole
• 3/5/25 – Reported Favorably Without Amendment
• 3/6/25 – PASSED Senate 33-3
• 3/6/25 – Received by House and Referred to Committee on Health Policy

Missouri 340B Drug Pricing Program Reporting

HB 2081
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/8/26 – Read Second Time

SB 1213
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee

SB 1178 
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee

Prohibiting Discrimination Against 340B Drug Entities by Insurers and PBMs

SB 1340
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/27/26 – Second Read and Referred S Families, Seniors, and Health Committee

SB 846
Read the Bill

• 12/1/25 – Prefiled
• 1/7/26 – Read First Time
• 1/8/26 – Referred to Insurance and Banking Committee

Increasing Transparency in the 340B Drug Pricing Program

HB 1755
Read the Bill

• 1/7/26 – Introduced and Referred to Health, Human Services and Elderly Affairs Committee
• 1/21/26 – Public Hearing – 11:30AM

SB 477
Read the Bill

• 1/7/26 – Introduced and Referred to Health and Human Services Committee
• 1/21/26 – Hearing – 1:30PM

340B Prescription Drug Anti-Discrimination Act

A6222
Read the Bill

• 1/7/26 – Referred to Health

S1913
Read the Bill

• 1/7/26 – Referred to Health
• 1/27/26 – Reported and committed to Finance

Prohibiting Restrictions on Contract Pharmacies

SB 278
Read the Bill

• 1/13/26 – Introduced and Referred to Committee on Education and Health
• 1/20/26 – Assigned to Subcommittee on Health
• 1/29/26 – Reported from Education and Health Committee with substitute; referred to Finance and Appropriations Committee

Protecting Patient Access to Discounted Medications via 340B Program

SB 5981
Read the Bill

• 1/5/26 – Prefiled
• 1/12/26 – Read First Time + Referred to Health & Long Term Care
• 1/16/26 – Hearing: 8AM
• 1/27/26 – Recommended do pass
• 1/28/26 – Referred to Ways & Means

HB 2145
Read the Bill

• 12/15/25 – Prefiled
• 1/12/26 – Read First Time + Referred to Health Care & Wellness
• 1/23/26 – Recommended do pass
• 1/28/26 – Referred to Appropriations